ReviewInternational journal of public health2025
What Lessons can Be Learned From the Management of the COVID-19 Pandemic?
Review in International journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Healthy Trust and Pandemic Readiness in the Context of Messenger RNA Vaccines: Protocol for a Sequential Deliberative Dialogue Study.JMIR research protocols · 2026Article
- The Imperative of Data Transparency for Pursuing Scientific Truth about COVID-19 Vaccination and Excess Deaths.JMA journal · 2026Article
- Reassessing Early COVID-19 Strategies in East Asia: Insights From Japan and Korea.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2026Review
- Review
- Epidemics, Ebola and the dignity of goodbye: how public health could respect culture.International journal of public health · 2026Article
- Strengthening pandemic preparedness in Peru: a qualitative study of high-level leaders involved in the COVID-19 response.BMJ public health · 2026Article
- SARS-CoV-2 mRNA Vaccine Effectiveness in the Borriana COVID-19 Cohort: A Prospective Population-Based Cohort Study.Epidemiologia (Basel, Switzerland) · 2025Article
- Urban riverbank green spaces as therapeutic environments: Examining the psychosocial benefits of square dance in aging populations in China.SSM - population health · 2025Article
- WHO'Frontiers in public health · 2025Article
- Response: "Letter to the Editor: Lessons to Be Learned From the COVID-19 Pandemic: Some Further Ideas".International journal of public health · 2025Article
- Lessons to Be Learned From the COVID-19 Pandemic: Some Further Ideas.International journal of public health · 2025Article
- Key lessons from the COVID-19 pandemic: Role of intensive care, politics and science communication (Review).Medicine internationalArticle
Corrections and comments
- Commented on by
Authors and funding
37 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the COVID-19 pandemic (2020-2023), governments around the world implemented an unprecedented array of non-pharmaceutical interventions (NPIs) to control the spread of SARS-CoV-2. From early 2021, these were accompanied by major population-wide COVID-19 vaccination programmes-often using novel mRNA/DNA technology, although some countries used traditional vaccines. Both the NPIs and the vaccine programmes were apparently justified by highly concerning model projections of how the pandemic could progress in their absence. Efforts to reduce the spread of misinformation during the pandemic meant that differing scientific opinions on each of these aspects inevitably received unequal weighting. In this perspective review, based on an international multi-disciplinary collaboration, we identify major problems with many aspects of these COVID-19 policies as they were implemented. We show how this resulted in adverse impacts for public health, society, and scientific progress. Therefore, we propose seven recommendations to reduce such adverse consequences in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.